BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25921830)

  • 1. Slow binding kinetics of secreted protein, acidic, rich in cysteine-VEGF interaction limit VEGF activation of VEGF receptor 2 and attenuate angiogenesis.
    Cydzik M; Abdul-Wahid A; Park S; Bourdeau A; Bowden K; Prodeus A; Kollara A; Brown TJ; Ringuette MJ; Gariépy J
    FASEB J; 2015 Aug; 29(8):3493-505. PubMed ID: 25921830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch signaling regulates tumor-induced angiogenesis in SPARC-overexpressed neuroblastoma.
    Gorantla B; Bhoopathi P; Chetty C; Gogineni VR; Sailaja GS; Gondi CS; Rao JS
    Angiogenesis; 2013 Jan; 16(1):85-100. PubMed ID: 22956186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of integrin-linked kinase with small interfering RNA inhibits VEGF-induced angiogenesis in retinal endothelial cells.
    Xie W; Zhao M; Zhou W; Guo L; Huang L; Yu W; Li X
    Ophthalmic Res; 2013; 49(3):139-49. PubMed ID: 23258222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells.
    Kupprion C; Motamed K; Sage EH
    J Biol Chem; 1998 Nov; 273(45):29635-40. PubMed ID: 9792673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel vasculo-angiogenic effect of cilostazol mediated by cross-talk between multiple signalling pathways including the ERK/p38 MAPK signalling transduction cascade.
    Chao TH; Tseng SY; Li YH; Liu PY; Cho CL; Shi GY; Wu HL; Chen JH
    Clin Sci (Lond); 2012 Aug; 123(3):147-59. PubMed ID: 22339730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity.
    Bagli E; Stefaniotou M; Morbidelli L; Ziche M; Psillas K; Murphy C; Fotsis T
    Cancer Res; 2004 Nov; 64(21):7936-46. PubMed ID: 15520200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
    Adya R; Tan BK; Punn A; Chen J; Randeva HS
    Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration.
    Xiong S; Grijalva R; Zhang L; Nguyen NT; Pisters PW; Pollock RE; Yu D
    Cancer Res; 2001 Feb; 61(4):1727-32. PubMed ID: 11245489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DICAM inhibits angiogenesis via suppression of AKT and p38 MAP kinase signalling.
    Han SW; Jung YK; Lee EJ; Park HR; Kim GW; Jeong JH; Han MS; Choi JY
    Cardiovasc Res; 2013 Apr; 98(1):73-82. PubMed ID: 23386276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of SPARC by VEGF in human vascular endothelial cells.
    Kato Y; Lewalle JM; Baba Y; Tsukuda M; Sakai N; Baba M; Kobayashi K; Koshika S; Nagashima Y; Frankenne F; Noël A; Foidart JM; Hata RI
    Biochem Biophys Res Commun; 2001 Sep; 287(2):422-6. PubMed ID: 11554745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycation of vitronectin inhibits VEGF-induced angiogenesis by uncoupling VEGF receptor-2-αvβ3 integrin cross-talk.
    Wang L; Zhang X; Pang N; Xiao L; Li Y; Chen N; Ren M; Deng X; Wu J
    Cell Death Dis; 2015 Jun; 6(6):e1796. PubMed ID: 26111058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Domain I-IV of β2-glycoprotein I inhibits advanced glycation end product-induced angiogenesis by down-regulating vascular endothelial growth factor 2 signaling.
    Wang QQ; Zhou SJ; Meng ZX; Wang J; Chen R; Lv L; Li CJ; Yu DM; Yu P
    Mol Med Rep; 2015 Mar; 11(3):2167-72. PubMed ID: 25405610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnolol suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting Ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways.
    Kim KM; Kim NS; Kim J; Park JS; Yi JM; Lee J; Bang OS
    Nutr Cancer; 2013; 65(8):1245-53. PubMed ID: 24066970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPARC suppresses lymph node metastasis by regulating the expression of VEGFs in ovarian carcinoma.
    Peng F; Zhong Y; Liu Y; Zhang Y; Xie Y; Lu Y; Zhang X; Li D
    Int J Oncol; 2017 Dec; 51(6):1920-1928. PubMed ID: 29075785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis.
    Kou B; Ni J; Vatish M; Singer DR
    Microcirculation; 2008 Apr; 15(3):251-67. PubMed ID: 18386220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABARBP down-regulates HIF-1α expression through the VEGFR-2 and PI3K/mTOR/4E-BP1 pathways.
    Park SH; Kim BR; Lee JH; Park ST; Lee SH; Dong SM; Rho SB
    Cell Signal; 2014 Jul; 26(7):1506-13. PubMed ID: 24686084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of afadin in vascular endothelial growth factor- and sphingosine 1-phosphate-induced angiogenesis.
    Tawa H; Rikitake Y; Takahashi M; Amano H; Miyata M; Satomi-Kobayashi S; Kinugasa M; Nagamatsu Y; Majima T; Ogita H; Miyoshi J; Hirata K; Takai Y
    Circ Res; 2010 Jun; 106(11):1731-42. PubMed ID: 20413783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diversity in human placental microvascular endothelial cells and macrovascular endothelial cells.
    Huang X; Jia L; Qian Z; Jia Y; Chen X; Xu X; Chang X; Liu M; Wang K
    Cytokine; 2018 Nov; 111():287-294. PubMed ID: 30269024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells.
    Dai J; Peng L; Fan K; Wang H; Wei R; Ji G; Cai J; Lu B; Li B; Zhang D; Kang Y; Tan M; Qian W; Guo Y
    Oncogene; 2009 Sep; 28(38):3412-22. PubMed ID: 19597469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.